171 related articles for article (PubMed ID: 34336006)
21. microRNA profiling for early detection of nonmelanoma skin cancer.
Balci S; Ayaz L; Gorur A; Yildirim Yaroglu H; Akbayir S; Dogruer Unal N; Bulut B; Tursen U; Tamer L
Clin Exp Dermatol; 2016 Jun; 41(4):346-51. PubMed ID: 26299703
[TBL] [Abstract][Full Text] [Related]
22. Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
Peng YH; Xu YW; Huang LS; Zhai TT; Dai LH; Qiu SQ; Yang YS; Chen WZ; Zhang LQ; Li EM; Xu LY
Cancer Prev Res (Phila); 2015 Aug; 8(8):729-36. PubMed ID: 25990085
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic efficiency of seven autoantibodies in lung cancer.
Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody biomarkers in the detection of cancer.
Cho-Chung YS
Biochim Biophys Acta; 2006 Jun; 1762(6):587-91. PubMed ID: 16730166
[TBL] [Abstract][Full Text] [Related]
25. Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer.
Tang T; Yang C; Brown HE; Huang J
Dis Markers; 2018; 2018():6184162. PubMed ID: 30245753
[TBL] [Abstract][Full Text] [Related]
26. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
27. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.
Chai Y; Peng B; Dai L; Qian W; Zhang Y; Zhang JY
Scand J Immunol; 2014 Nov; 80(5):362-8. PubMed ID: 24965442
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
30. Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients.
Ghahartars M; Najafzadeh S; Abtahi S; Fattahi MJ; Ghaderi A
Dermatol Res Pract; 2018; 2018():8321302. PubMed ID: 30581461
[TBL] [Abstract][Full Text] [Related]
31. Skin cancers in Croatia, 2003-2005: epidemiological study.
Lipozencić J; Celić D; Strnad M; Toncić RJ; Pasić A; Rados J; Znaor A
Coll Antropol; 2010 Sep; 34(3):865-9. PubMed ID: 20977074
[TBL] [Abstract][Full Text] [Related]
32. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
[TBL] [Abstract][Full Text] [Related]
33. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
34. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological evaluation of nonmelanoma skin cancer.
Adinarayan M; Krishnamurthy SP
Indian J Dermatol; 2011 Nov; 56(6):670-2. PubMed ID: 22345768
[TBL] [Abstract][Full Text] [Related]
36. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
37. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
38. Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis.
Xia J; Shi J; Wang P; Song C; Wang K; Zhang J; Ye H
Scand J Immunol; 2016 Jun; 83(6):393-408. PubMed ID: 26991924
[TBL] [Abstract][Full Text] [Related]
39. Pattern of Nonmelanoma Skin Cancers in Sikkim, India: A 3-year Clinicopathological Review.
Baruah B; Sengupta S; Kesari SP; Ilapakurty B
Indian J Otolaryngol Head Neck Surg; 2013 Jul; 65(Suppl 1):160-2. PubMed ID: 24427635
[TBL] [Abstract][Full Text] [Related]
40. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians.
Halpern AC; Hanson LJ
Int J Dermatol; 2004 Sep; 43(9):638-42. PubMed ID: 15357741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
